An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.
List view / Grid view
European Pharmaceutical Review
Filter the results
The DHSC has confirmed that several pharmaceutical industry bodies have agreed to NDAs regarding plans for a no-deal Brexit.
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
2019 has seen a marked increase of antibody biosimilar product approvals in the first half of the year, according to a report.
Pharma contract placement was found to increase by 250 percent compared to last year, according to figures from a recruitment firm.
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
A new study undertaken to better understand the economic impact of brand-brand competition finds this does not lower drug prices.
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
Scientists have developed microrobots that can deliver medication to specific spots inside the body while being controlled from outside the patient.
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®.
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.